Monica Di Luca - Curriculum Vitae#

• Laurea cum laude in Chemistry and Pharmacology Technology, Faculty of Pharmacy, University of Milan - 110 lode/110 (1986)
  
• PhD in "Pharmacology", Faculty of Pharmacy, University of Milan (1992)
  
• PhD in Medical Sciences, School of Medicine, University of Utrecht (1993)
  

• Vice-Rector for Research, University of Milano: 2024
  
• Director, Dept of Pharmacological and Biomolecular Sciences, University of Milano: 2020 - 2024
  
• Vice - Rector for International Strategies, University of Milano: 2014 - 2018
  
• Director of NeuroNest (Center of Neuroscience of University of Milano): 2014 - 2018
  
• Full Professor of Pharmacology - University of Milano (2011 - present)
  
• Associated Professor of Pharmacology - University of Milano (2000 - 2011)
  
• Assistant professor, Institute of Pharmacological Sciences University of Milano (1995 - 2000)

• EPHAR Rodolfo Paoletti Award for Excellence in Pharmacology (2024)
  
• Doctor Honoris Causa University of Bordeaux (Oct 2019)
  
• Laurea Honoris Causa Faculty of Medicine and Pharmacy, Univ. of Mons (Belgium) (March 2017)
  
• EMBO membership (2017)
  
• ENCP Media Award (2013)
  
• EDAB, European Dana Alliance Invited Member (2008)

• EBC - European Brain Council (Member of Advisory Board: 2003-2006; Vice-president: 2010-2016; President: 2017- 2021)
  
• IBRO, International Brain Organization (Chair of Western Europe Regional Committee: 2006-2010; Executive Director Inter-Regional activities, 2010-2014)
  
• FENS - Federation of European Neuroscience Societies (Member of Scientific Programme Committee: 1996-2000; General Secretary: 2000-2006; Member of Board Programme of European Neuroscience Schools, PENS: 2006-2010; President 2014 - 2016)
  
• Federation of European Neuroscience Societies Trust (President: 2006 – 2014)
  
• SfN - Society for Neuroscience (Member of Women in Neuroscience Committee: 2007 - 2010; Member of Professional Development Committee: 2009 - 2012)
  
• SINS - Società Italiana di Neuroscienze (Board Member 2001-2005; President Elect 2021)
  
• SIF - Società Italiana di Farmacologia (Coordinator for "Regione Lombardia": 2007-oggi; Coordinator Group of Neurodegenerative Diseases: 2012; Board Member: 2013-2017; President Elect: 2025

• Italian Ministry of University and Research (FIS Advanced 2021, PRIN 2017, PRIN2015, PRIN2010-11, FIRB2011, PRIN2008, FIRB2003)
  
• Italian Ministry of Health (Min.San. 2019, 2016, 2010, 2008, 2004, 2002, 2000)
  
• CNR (1999, 1998, 1995)
  
• European Commission (HE: Eternity; H2020: EBRA-2019; H2020-MSCA-ITN-2015; JPco-fuND, STAD project 2016;FP7 SymBAD ITN; FP7 REPLACES Collaborative project; FP7 cPADS, IAPP project, FP6 SynScaff Collaborative projects)
• Foundations (Cariplo, IPSEN, Telethon, AlzOrg)

• European patent application EP 13196710.1 - 1456 (ADAM10 inhibition to treat Fragile X syndrome), registered on 11/12/2013.